Featured Research

from universities, journals, and other organizations

Urgent need to improve quality of outpatient care in public and private sector in poorer countries

Date:
April 12, 2011
Source:
Public Library of Science
Summary:
The overall poor quality of outpatient health care in both the formal private and public sector in low and middle income countries is worrying -- especially given the increasing volume of chronic conditions, such as diabetes and heart disease, which require relatively sophisticated, long-term outpatient medical care.

The overall poor quality of outpatient healthcare in both the formal private and public sector in low and middle income countries is worrying -- especially given the increasing volume of chronic conditions, such as diabetes and heart disease, which require relatively sophisticated, long-term outpatient medical care.

This conclusion, from a review by Paul Garner from the Liverpool School of Tropical Medicine, Liverpool, UK and colleagues and published in this week's PLoS Medicine, stresses the pressing need for national governments to find and implement effective strategies to improve the quality of healthcare provided in both sectors in order to improve health outcomes in low and middle income countries.

In their review, the authors systematically identified, summarized, and scored the results of studies that directly compared the quality of outpatient care in low and middle income countries offered by public providers with the care offered by ''formal'' private providers (recognized by law) and ''informal'' private providers (providers that are not legally recognized, such as shopkeepers).

The authors found that overall many services, irrespective of whether public or private, scored low (less than 50%) on infrastructure, clinical competence, and practice. Generally, the formal private sector performed better in relation to drug supply, responsiveness, and effort, but there was no detectable difference between health provider groups for patient satisfaction.

The authors put their findings in context: "Many efforts to improve the quality of ambulatory care are restricted to the public sector on the grounds that public funds should be reserved for the public sector because that is where the poor turn for their health care. But concentrating on the public sector misses a large proportion, the majority in some cases, of the providers used by the poor."

They continue: "Raising the quality of care delivered by private, as well as public, providers would, in fact, be a pro-poor intervention as it would improve the effectiveness of the money the poor spend on health care."

In an accompanying Perspective article, Jishnu Das (uninvolved in the research) from the World Bank and the Centre for Policy Research, New Delhi, India says: "The review reflects a logical initial focus in the literature on individual providers rather than the interactions between providers; going forward, broadening the discussion on quality to health care markets can generate valuable insights for policy."

He continues: "Such market-level analysis can help answer policy questions ranging from regulatory issues to the trade-off between access and quality."

Funding: This research was funded by the UK Department for International Development for the benefit of the poor in developing countries.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sima Berendes, Peter Heywood, Sandy Oliver, Paul Garner. Quality of Private and Public Ambulatory Health Care in Low and Middle Income Countries: Systematic Review of Comparative Studies. PLoS Medicine, 2011; 8 (4): e1000433 DOI: 10.1371/journal.pmed.1000433

Cite This Page:

Public Library of Science. "Urgent need to improve quality of outpatient care in public and private sector in poorer countries." ScienceDaily. ScienceDaily, 12 April 2011. <www.sciencedaily.com/releases/2011/04/110412171155.htm>.
Public Library of Science. (2011, April 12). Urgent need to improve quality of outpatient care in public and private sector in poorer countries. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/04/110412171155.htm
Public Library of Science. "Urgent need to improve quality of outpatient care in public and private sector in poorer countries." ScienceDaily. www.sciencedaily.com/releases/2011/04/110412171155.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins